...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics Corp. Commences Operations

BDAZ,

It's been a long week for me at work, does that statement mean that only the holders of the Royalty Preferred shares would benefit from said royalties mentioned?

Thanks

Share
New Message
Please login to post a reply